<DOC>
	<DOCNO>NCT00765076</DOCNO>
	<brief_summary>This clinical trial aim study immunogenicity GSK Biologicals ' influenza vaccine GSK2186877A people age 65 year old .</brief_summary>
	<brief_title>Clinical Study Immunogenicity GSK Biologicals ' Influenza Vaccine GSK2186877A People Aged 65 Years Older</brief_title>
	<detailed_description>The amendment protocol posting : minor change one inclusion criterion one secondary outcome measure .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>All subject must satisfy follow criterion study entry : Subjects investigator believe comply requirement protocol enrol study . Specific attention give compliance potential subject suspect known drug alcohol abuse . Written inform consent obtain subject . Free acute aggravation health status establish medical history clinical examination enter study . Elderly adult : â€¢ A man woman 65 year age old time first vaccination . Young adult : Man woman age 18 40 year , inclusive . If subject female , must nonchildbearing potential postmenopausal , childbearing potential , must practice adequate contraception 30 day prior vaccination , negative pregnancy test continue precaution 2 month vaccination . Use investigational nonregistered product ( drug vaccine ) study vaccine ( ) within 30 day prior vaccination , plan use study period . Administration license vaccine within 2 week ( inactivated vaccine ) 4 week ( live vaccine ) prior enrolment study . Planned administration vaccine foreseen study protocol Visit 4 vaccination influenza vaccine study vaccine Visit 4 . Vaccination influenza since February 2008 seasonal influenza vaccine . Previous vaccination last three year investigational adjuvanted vaccine candidate seasonal pandemic influenza vaccine . Chronic administration ( defined 14 day ) immunosuppressant immunemodifying drug within six month prior first vaccine dose . Any confirm suspected immunosuppressive immunodeficient condition , base medical history physical examination . History hypersensivity previous dose influenza vaccine . History allergy reaction likely exacerbate component vaccine ( ) include egg chicken protein . Acute ( active ) clinically significant pulmonary , cardiovascular , hepatic renal functional abnormality , determine clinical evaluation preexist laboratory screening test . Acute disease time enrolment . Administration immunoglobulins and/or blood product within three month precede first administration study vaccine plan administration study . Any medical condition intramuscular injection contraindicate . Pregnant lactate female . Female childbearing age planning become pregnant planning discontinue contraceptive precaution . Any medical condition opinion investigator precludes collection blood volume require protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Vaccine</keyword>
	<keyword>Elderly</keyword>
	<keyword>Influenza</keyword>
</DOC>